Speakers

Andrew Anzalone, MD, PhD

Co-Founder and Head of Platform

Prime Medicine

Carolyn Mazzitelli, PhD

Executive Director

Ionis Pharmaceuticals

David J. Craik, PhD

Professor of Biomolecular Structure

University of Queensland

Devan Shah

Founder & Chief Executive Officer

RNAV8 Bio

Elissa Hobert, PhD

Senior Director of Discovery Technologies

Souffle Therapeutics

Fernando Albericio, PhD

Research Professor, School of Chemistry

University of Kwazulu-Natal

Florence Brunel, PhD

Senior Principal Scientist

Novo Nordisk

Fran Wincott, PhD

President

Wincott & Associates, LLC

Ian Huggins, PhD

Senior Director, Delivery Services

Aerska

Ivan Zlatev, PhD

Executive Director of Research

Alnylam Pharmaceuticals

Dr. Jane Grogan, PhD

Executive Vice President & Head of Research

Biogen

John Finn, PhD

Chief Scientific Officer

Basecamp Research

John Maraganore, PhD

Founding CEO, Alnylam & CEO and Principal

JMM Innovations, LLC

John Zuris, PhD

Principal

John Zuris Consulting LLC

Dr. Julia Alterman, Ph.D.

Assistant Professor, RNA Therapeutics Institute

University of Massachusetts Chan Medical

Kaijiong Xiao, PhD

Principal Scientist, Process Research & Development

Merck

Kathryn Ackley, PhD

CMC Consultant Specializing in Oligonucleotides

Independent Consultant

Kevin Cole, PhD

Executive Director, Bioproduct Research and Development

Eli Lilly and Company

Kristy Wood, PhD

Senior Vice President, Technical Operations

Intellia Therapeutics

Li Xiao, PhD

Director, Synthetic Molecule Design & Development

Eli Lilly and Company

Lori Troup

Director of Analytical Development

Novo Nordisk

Louise Dalboge, PhD

Chief Scientific Officer

Gubra Biotech

Luis Brito, PhD

Vice President, Delivery Platform

Beam Therapeutics

Marc Jacob, PhD

Head of Strategic Development, Chromatography Products

YMC America

Matteo Villain, PhD

Vice President of Peptides and Oligonucleotides

Veranova

Mike Webb, Ph.D.

Founder and CEO

Mike Webb Pharma

Patrick C. Reid, PhD

President and CEO

PeptiDream, Inc.

Patrick Knerr, PhD

Vice President, Metabolic Translational Research

Indiana Biosciences Research Institute

Ranganath Gopalakrishnan, PhD

Senior Director and Senior Principal Scientist

Zealand Pharma

Ratmir Derda, PhD

Founder and CSO, 48 Hour Discovery

University of Alberta

Roman Hillebrand, PhD

Co-founder and CTO/COO

OligoStream Industries

Rowshon Alam, PhD

Vice President, Head of Chemistry

Prime Medicine

Rubina Parmar,

PhD

Atlas Ventures

Saul Martinez Montero, PhD

Executive Director, RNA Therapeutics

Dyne Therapeutics

Seth Alexander, PhD

Director, Enterprise AI

Prime Medicine

Tina Boville, PhD

CEO

Aralez Bio

Todd Maloney, PhD

Associate Vice President of Analytical Chemistry

Eli Lilly & Company

Troels Koch, PhD

Chief Technology Officer

Cora Biosciences

William Kiesman, PhD

Chief Technology Officer

Judo Bio

Yogesh S. Sanghvi, PhD

President

Rasayan Inc.